Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipid Profile- the Role of Baseline Vitamin D Levels

NCT07043361 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT07043361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07043361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipid Profile- the Role of Baseline Vitamin D Levels
Lead sponsor
Hillel Yaffe Medical Center
Phase
Observational
Overall status
Completed
Start date
December 18, 2023
Completion date
April 30, 2025
Enrollment
5,300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disease